In addition, the differential response to MAL-PDT in HNSCC could be also related to the signalling cascade triggered by the nuclear localization of GSK3β by regulating the localization and expression of the transcription factor NF-κβ, related to resistance against a variety of antitumoral treatments. Here, NFKB1 is linked to head and neck squamous cell carcinoma.